MS Flashcards

1
Q

MS

A

NO CURE -
Characterized by segmental demyelination of nerve fibers of brain and spinal cord
Periods of remission and exacerbation more progressive hen diagnosed at age >50 affects most women between 20-50
Enviromental factors (temperate climates)
Plaque formation on spinal cord and brain (seen on MRI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Causes MS

A

No known causes but can be Infection smoking physical injury emotional stress excessive fatigue pregnancy poor state of health genetic component
Mostly occurs in women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

With women who get diagnosed with MS after 50

A

No signs of remission and excerbations
But have progressive deterioration in some pt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical manifestations

A

Chronic progressive deterioration in some pt (women older than 50)
Remissions and exacerbations in others
Overall trend progressive detestation in neuro function
Plaque build up on spinal cord and brain ( CNS) (on MRI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Tremors in MS

A

Intestional tremors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why does it take so long to get diagnosed with MS

A

Vague symptoms in the beginning,not enough to seek medical treatment
Will rule everything out before you get diagnosed with MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Multiple sclerosis s/s common

A

Visual (blurred or double, blindness in one eye)
Motor problems- gait difficulties/assisted devices
Sensory problems(facial numbness ,
Inkling)
Cerebella’s problems
Bowel,bladder and sexual
Cognitive
Emotional problems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Death in MS pt

A

Not because of MS but from immobility , or pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sensory manifestations

A

Numbness pain tremor
Decrease hearing
Chronic neuro pain
Llermitte’ssign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Motor manifestations

A

Weakness or paralysis
Spasticity of muscles
Scanning of speech

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Impaired bowel and bladder functions

A

Spastic bladder
Constipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Sexual dysfunction

A

Erectile dysfunction
Decrease libido
Painful intercourse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cognitive manifestations

A

Short term memory attention
Info processing
Attention , planning
Visual perception word finding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MS diagnostic studies

A

No definitive test for MS
H&P , clinical manifestations and result of diagnostic test
MRI
CSF analysis
Evoked potential studies
Neuropsychological testing
Sexual history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

For diagnosis of MS

A

Evidence of at least 2 inflammatory demyelination’s lesions in at least 2 different locations within the CNS
Damage or an attack occurring at different times (usually > 1 month apart)
All other diagnosis must be ruled out

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

MS medical management

A

No cure
Goal is to delay progression of disease manage chronic symptoms and treat acute exacerbations

17
Q

Immunomodulaators (disease modifying drugs I)

A

Interferon beta-1a
Interferon bet-1b
Glatiramer acetate
Teriflunamide

18
Q

Interferon beta

A

Is a naturally occurring glycoprotein with antiviral , antiproliferative , antimmunomodulatory actions

Reduced the frequency and severity of attacks
Reduces the number and size of lesions detectable with MRI

Delays progression of disability
Given subq or IM injections

19
Q

Adverse effects and drug interactions INterferon beta

A

Flu like reactions
Hepatotoxicity (liver function test,CBC)
Myelosuppression
Injection - site reactions
Depression
Suicidal thoughts
Drug reactions

20
Q

PREPERATION dosage and admin of interferon beta

A

Dispense as single use syringes and vials

21
Q

Disease modifying drugs II
Immunosuppressant

A

Only one approved by the US food and drug admin
Mitoxantrone

22
Q

Mitoxantrone

A

More toxic than immunommodulators
Produce greater suppression of immune function
Originally developed to treat cancer can delay time to relapse and time of disability progression

23
Q

Therapeutic use of mitoxantrone

A

Decreases neuro disability and clinical relapses

Binds with DNA and inhibits topoisomerase

24
Q

Adverse effects and drug interactions

A

Myelosuppression (monitor fever chills and cough inform physician immediately )
Cardio toxicity
Fetal harm
Reversible hair loss, injury to GI ucosa n&V
Amenorrhea , allergy symptoms and blue green tint to urine and Sclera

25
Drug therapy for MS
Corticosteroids Prednisone and methylprednisolone Medication to manage symptoms (bowel dysfunction , etc)
26
Medication for spastic muscles
Backlafin
27
Medication for neuropathic pain
Gabapentin
28
Medication to help with walking
Dalfampridine
29
Nursing interventions
Promote physical mobility Prevent injury Enhance bowel and bladder control Enhance communication Improve sensory and cognitive function Teach about medications Educate family Gait training
30
Interproffesional care
Surgery Dorsal column electrical stimulation Intrathecal baclofen pump
31
Therapy for MS
Water therapy
32
Psychological
Anger anxiety depression acceptance
33
Social system
Family Financially Friends
34
Counseling
Individual Family support group